Details

Autor(en) / Beteiligte

• Liga, Riccardo
• Gimelli, Alessia
• De Carlo, Marco
• Marzullo, Paolo
• Pedrinelli, Roberto
• Petronio, Anna Sonia

Titel

Cardiac sympathetic dysfunction in left ventricular hypertrophy caused by arterial hypertension and degenerative aortic stenosis

Ist Teil von

• Journal of nuclear cardiology, 2022-02, Vol.29 (1), p.337-347

Ort / Verlag

Cham: Elsevier Inc

Erscheinungsjahr

2022

Quelle

SpringerLink

Beschreibungen/Notizen

• To evaluate cardiac sympathetic innervation in hypertensive patients with left ventricular (LV) hypertrophy (H) and aortic stenosis (AS) submitted to transcatheter aortic valve implantation (TAVI). Twenty-two hypertensive elders (82 ± 5 years) with severe AS and significant LVH (> 122 g·m−2 in women and > 149 g·m−2 in men) were compared with 14 patients with uncomplicated essential hypertension (HT) with similar degree of LVH and 10 controls. 123I-metaiodobenzylguanidine (MIBG) and 99mTc-tetrofosmin SPECT acquisitions were obtained to assess sympathetic innervation and LV perfusion. The innervation/perfusion mismatch score was taken as an indicator of cardiac sympathetic dysfunction. The imaging protocol was repeated 6 months after TAVI. Regional MIBG uptake was more heterogeneous in HT and AS patients than controls, and therefore, innervation/perfusion mismatch score was higher in both AS (9 ± 8) and HT (5 ± 2) than controls (1 ± 1, P < .001). On multivariate analysis, significant LVH was the major predictor of impaired LV sympathetic innervation (OR 19.45, 95% CI 1.87-201.92; P = .013). After TAVI, no differences in measures of LV sympathetic innervation were evident, although only a marginal LV mass reduction was observed (− 5.4 ± 2.4 g). Cardiac sympathetic innervation is impaired in patients with LVH, either with AS or not, and is not impacted significantly by TAVI procedure.